Qiagen N.V. (FRA:QIA)

Market Cap	8.50B
Revenue (ttm)	1.85B
Net Income (ttm)	86.67M
Shares Out	n/a
EPS (ttm)	0.39
PE Ratio	98.10
Forward PE	18.76
Dividend	1.21 (3.03%)
Ex-Dividend Date	Jan 29, 2025

Volume	1,981
Average Volume	1,152
Open	39.41
Previous Close	39.83
Day's Range	39.28 - 39.66
52-Week Range	32.50 - 47.53
Beta	n/a
RSI	63.70
Earnings Date	May 7, 2025

About Qiagen

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and...

• Industry: Laboratory Analytical Instruments
• Founded: 1984
• Employees: 5,396
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: QIA

Financial Performance

In 2024, Qiagen's revenue was $1.98 billion, an increase of 0.66% compared to the previous year's $1.97 billion. Earnings were $83.59 million, a decrease of -75.51%.

Financial numbers in USD